Bio Green Med Solution is trading at $0.87 (-7.25%), with no clear company-specific catalyst identified for the September 29 decline. - The latest news item found was a September 28 merger-related class-action investigation; it did not link the investigation to the share-price move. - Shares had already weakened from $0.96 on September 23 to $0.90 on September 28. - Broad indexes were only slightly lower in the supplied market context, which does not establish a broader-market explanation.